NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Aenitis Technologies

Aenitis Technologies

Private
ParisHealthcare & Life Scienceshttps://www.aenitis.fr/

Last Round

VC Round

Oct 10, 2024

Total Funding Raised

$10.44M

Company Overview

Aenitis Technologies is a biotechnology company that develops and markets acoustofluidic technology for contact-free cell handling, sorting, and filtration to make cell and gene therapy manufacturing safer and less expensive.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

acoustofluidicscell processingacoustophoresisbioprocessingcell therapy manufacturingacoustic cell manipulationlab-on-a-chipbiomanufacturingGMP bioprocessingmicrofluidicsmodular type packageMTPcontract development and manufacturing organizationCDMOsingle-use consumablesbiotech hardware

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aenitis Technologies Comps

Public and private peers based on sector, stage, and business model.

Aenitis Technologies comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Aenitis Technologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundOct 10, 2024
GrantDec 10, 2019
GrantDec 11, 2018
Series AAug 19, 2018
GrantNov 30, 2017
Seed
Oct 19, 2016

Key People

Founding team and executive leadership

Emmanuel VINCENT

Chief Executive Officer

Executive Team

Emmanuel VINCENT-BALLEREAU

CEO

Executive Team

Aenitis Technologies Investors

Notable investors and investment history

Aenitis Technologies investors
InvestorRounds
Stamos Capital PartnersVC Round
Horizon 2020Grant
European Innovation Council FundVC Round
Weaving InvestVC Round
European CommissionGrant
BpifranceGrant
Seventure PartnersSeed, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 8, 2025

    Signed a Memorandum of Understanding (MOU) with the global pharmaceutical company.

  • Oct 10, 2024

    $7M round led by European Innovation Council and Seventure Partners.

Aenitis Technologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Aenitis Technologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Aenitis Technologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis
Employee Range13
Year Founded2014
Last FundingOct 10, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.